• Home
  • News

Sichenzia Ross Friedman Ference LLP Represents LaidLaw & Company (UK) Ltd. on $5.0M Registered Direct Offering of Actinium Pharmaceuticals, Inc

actinium pharmaceuticals

June 18, 2015 – New York, NY – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented the sole placement agent Laidlaw & Company (UK) in a registered direct offering of Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM),  a biopharmaceutical company developing innovative targeted immunotherapeutics for the treatment of advanced cancers. The offering consisted of 1,923,078 shares of the Company’s common stock issued at a purchase price of $2.60 per share for aggregate gross proceeds ofapproximately $5,000,000.

The Sichenzia Ross Friedman Ference LLP team was led by Partners Richard A. Friedman and Stephen A. Cohen


Sichenzia Ross Ference LLP
Latest posts by Sichenzia Ross Ference LLP (see all)